Referanslar

• 1. Karaarslan Z.Ö., Serin M.S. (2016): Hastalıkların tanı ve tedavi stratejilerinde miRNA ve diğer non-proteincoding RNA’lar. Mersin Univ Saglık Bilim Derg,(9)3. google scholar
• 2. Zhang F, Zhang R, Zhang X, Wu Y, Li X, Zhang S, Hou W, Ding Y, Tian J, Sun L, Kong X. (2018): Comprehensive analysis of circRNA expression pattern and circRNAmiRNA-mRNA network in the pathogenesis of atherosclerosis in rabbits.Aging (Albany NY), 10(9):2266-2283. google scholar
• 3. Klattenhoff CA, Scheuermann JC, Surface LE, Bradley RK, Fields PA, Steinhauser ML, ve ark. (2013): Braveheart, a long noncoding RNA required for cardiovascular lineage commitment. Cell, 152(3): 570583. google scholar
• 4. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A, ve ark. (2014):Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res, 114(10): 1569-1575. google scholar
• 5. Archer K, Broskova Z, Bayoumi AS, Teoh JP, Davila A, Tang Y, ve ark. (2015): Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases. Int J Mol Sci, 16(10): 23651-23667. google scholar
• 6. Wang W, Wang Y, Piao H, Li B, Huang M, Zhu Z, Li D, Wang T, Xu R, Liu K. (2019): Circular RNAs as potential biomarkers and therapeutics for cardiovascular disease. PeerJ, 7:e6831. google scholar
• 7. Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, et al. (2015): The landscape of long noncoding RNAs in the human transcriptome. Nat Genet., 47:199–208. google scholar
• 8. Scheuermann JC, Boyer LA. (2013): Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO J., 32(13): 1805-1816. google scholar
• 9. Bayoğlu B, Cengiz M. (2017): Kalp ve Damar Hastalıklarında Uzun Kodlanmayan RNA Transkriptlerinin Rolleri. Bezmialem Science, 5: 74-79. google scholar
• 10. Lee JT. (2012): Epigenetic regulation by long noncoding RNAs. Science, 338(6113): 1435-1439. google scholar
• 11. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, ve ark. (2007): RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science, 316(5830): 1484-1488. google scholar
• 12. Sana J, Faltejskova P, Svoboda M, Slaby O. (2012) Novel classes of non-coding RNAs and cancer. J Transl Med., 10: 103. google scholar
• 13. Tian D, Sun S, Lee JT. (2010): The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation. Cell.,143(3): 390-403. google scholar
• 14. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, ve ark. (2011): Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet, 43(7): 621-629. google scholar
• 15. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, ve ark. (2010): The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell, 39(6): 925-938. google scholar
• 16. Wang KC, Chang HY. (2011): Molecular mechanisms of long noncoding RNAs. Mol Cell, 43(6): 904-914. google scholar
• 17. Bayoumi AS, Aonuma T, Teoh JP, Tang YL, Kim IM. (2018): Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases. Acta Pharmacol Sin., 39(7):1100-1109. google scholar
• 18. Schwartz SM. (1997): Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest, 100(11 Suppl): S87-89. google scholar
• 19. Motterle A, Pu X, Wood H, Xiao Q, Gor S, Ng FL, ve ark.( 2012): Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet, 21(18): 4021-4029. google scholar
• 20. Holdt LM, Teupser D. (2012): Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. Arterioscler Thromb Vasc Biol, 32(2): 196-206. 21. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, ve ark. (2007): Genomewide association analysis of coronary artery disease. N Engl J Med, 357(5): 443-453. google scholar
• 22. Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K, ve ark. (2013): Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet, 9(7): e1003588. google scholar
• 23. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, Bergert H, ve ark. (2010): ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol, 30(3): 620-627. google scholar
• 24. Li H, Zhu H, Ge J. (2016): Long Noncoding RNA: Recent Updates in Atherosclerosis. Int J Biol Sci, 12(7): 898-910. google scholar
• 25. Nabel EG, Braunwald E. (2012): A tale of coronary artery disease and myocardial infarction. N Engl J Med, 366(1): 54-63. google scholar
• 26. Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T, ve ark. (2014): Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res, 114(9): 1389-1397. google scholar
• 27. Hu YW, Yang JY, Ma X, Chen ZP, Hu YR, Zhao JY, ve ark. (2014): A lincRNA-DYNLRB2-2/GPR119/GLP-1R/ ABCA1-dependent signal transduction pathway is essential for the regulation of cholesterol homeostasis. J Lipid Res, 55(4): 681-697. google scholar
• 28. Hu YW, Zhao JY, Li SF, Huang JL, Qiu YR, Ma X, ve ark. (2015): RP5-833A20.1/miR-382-5p/NFIAdependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction. Arterioscler Thromb Vasc Biol, 35(1): 87-101. google scholar
• 29. Şengül C. (2006): Genç Yaşta Miyokard Enfarktüsü Geçiren Hastalarda Klasik Ve Psikososyal Risk Faktörlerinin Karşılaştırmalı Olarak İncelenmesi. Kardiyoloji Uzmanlık Tezi, İstanbul. google scholar
• 30. Vausort M, Wagner DR, Devaux Y. (2014): Long noncoding RNAs in patients with acute myocardial infarction. Circ Res, 115(7): 668-677. google scholar
• 31. Lu Y, Meng X, Wang L, Wang X. (2018): Analysis of long non-coding RNA expression profiles identifies functional lncRNAs associated with the progression of acute coronary syndromes. Exp Ther Med, 15(2): 1376-1384. google scholar
• 32. Wang K., Liu C.Y., Zhou L.Y., Wang J.X., Wang M. ve ark. (2015): APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun, 10;6:6779. google scholar
• 33. White HD, ed Unstable Angina: Ischemic Syndromes. 3 ed. Philadelphia: Lippincott Williams & Wilkins; 2007. Topol EJ, ed. Textbook of cardiovascular medicine. google scholar
• 34. Cai Y, Yang Y, Chen X, Wu G, Zhang X, Liu Y, ve ark. (2016): Circulating ‘lncRNA OTTHUMT00000387022’ from monocytes as a novel biomarker for coronary artery disease. Cardiovasc Res, 112(3): 714-724. google scholar
• 35. Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, ve ark. (2016): Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun., 7:12429. google scholar
• 36. Holdt LM, Teupser D. (2018): Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis. Front Cardiovasc Med., 6;5:145. google scholar
• 37. Rankin CR, Lokhandwala ZA, Huang R, Pekow J, Pothoulakis C, Padua D. (2019): Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation. Life Sci., 231:116571. google scholar
• 38. Salgado-Somoza A, Zhang L, Vausort M, Devaux Y. (2017): The circular RNA MICRA for risk stratification after myocardial infarction. International Journal of Cardiology, Heart andVasculature 17:33–36. google scholar
• 39. Yang Y, Cai Y, Wu G, Chen X, Liu Y, Wang X, ve ark. (2015): Plasma long non-coding RNA, CoroMarker, a novel biomarker for diagnosis of coronary artery disease. Clin Sci (Lond), 129(8): 675-685. google scholar

Atıflar